Compare · DMII vs PNTM
DMII vs PNTM
Side-by-side comparison of Drugs Made In America Acquisition II Corp. (DMII) and Pontem Corporation (PNTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DMII and PNTM operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM carries a market cap of $838.8M.
- DMII has hit the wire 1 time in the past 4 weeks while PNTM has been quiet.
PNTM
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest DMII
- SEC Form 10-K filed by Drugs Made In America Acquisition II Corp.
- Drugs Made In America Acquisition II Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form NT 10-K filed by Drugs Made In America Acquisition II Corp.
- Drugs Made In America Acquisition II Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Drugs Made In America Acquisition II Corp. filed SEC Form 8-K: Other Events
- Drugs Made In America Acquisition II Corp. filed SEC Form 8-K: Leadership Update
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits